# Transdermal Basal Insulin Patch Study in Type 1 Diabetes

> **NCT00519623** · PHASE1,PHASE2 · COMPLETED · sponsor: **Altea Therapeutics** · enrollment: 9 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **OTHER:** PassPort(R) Transdermal Insulin Delivery System

## Key facts

- **NCT ID:** NCT00519623
- **Lead sponsor:** Altea Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2007-11
- **Final completion:** 2007-12
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2010-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00519623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00519623, "Transdermal Basal Insulin Patch Study in Type 1 Diabetes". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00519623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*